Clinical Trial Update: Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing a three-drug regimen (vinorelbine, gemcitabine, and docetaxel) with a two-drug regimen (paclitaxel and carboplatin) in advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Japan Multinational Trial Organization | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED